Bill
Bill > A4682
NJ A4682
NJ A4682Prohibits health insurance carriers from denying coverage of nonopioid prescription drugs in favor of opioid prescription drugs.
summary
Introduced
09/12/2024
09/12/2024
In Committee
09/12/2024
09/12/2024
Crossed Over
Passed
Dead
01/12/2026
01/12/2026
Introduced Session
2024-2025 Regular Session
Bill Summary
This bill makes it unlawful when a licensed health care provider prescribes a nonopioid medication to a person covered by a health insurance carrier for the treatment of acute pain and the carrier denies coverage of a nonopioid prescription drug: (1) in favor of an opioid prescription drug; or (2) to require a covered person to try an opioid prescription drug prior to approving the use of a nonopioid prescription drug. "Carrier" is defined in the bill to mean an insurance company, health service corporation, hospital service corporation, medical service corporation, or health maintenance organization authorized to issue health benefits plans in this State. Under the bill, a carrier that establishes and maintains a drug formulary is to ensure that a nonopioid drug approved by the United States Food and Drug Administration for the treatment or management of pain will not be disadvantaged or discouraged, with respect to coverage or cost-sharing, relative to any opioid or narcotic drug for the treatment or management of pain on the formulary of the carrier under various circumstances. It is not prohibited in the bill for an opioid drug to be preferred over another opioid drug or for a nonopioid drug to be preferred over another nonopioid drug. The provisions of the bill prohibiting denial of a nonopioid prescription drug are also incorporated into the laws governing the required coverage for contracts negotiated by the State Health Benefits Commission and the School Employees' Health Benefits Commission, and in the law overseeing Medicaid.
AI Summary
This bill prohibits health insurance carriers from denying coverage of nonopioid prescription drugs in favor of opioid prescription drugs. It requires carriers to ensure that nonopioid drugs approved by the FDA for pain treatment are not disadvantaged or discouraged compared to opioid drugs in terms of coverage or cost-sharing. The provisions of the bill also apply to health benefits plans purchased by the State Health Benefits Commission, the School Employees' Health Benefits Commission, and Medicaid. The bill will take effect on January 1, 2026 and apply to policies, plans, and contracts renewed or issued on or after that date.
Committee Categories
Business and Industry
Sponsors (6)
Margie Donlon (D)*,
Carol Murphy (D)*,
Anthony Verrelli (D)*,
Mitchelle Drulis (D),
Roy Freiman (D),
Ellen Park (D),
Last Action
Introduced, Referred to Assembly Financial Institutions and Insurance Committee (on 09/12/2024)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.njleg.state.nj.us/bill-search/2024/A4682 |
| BillText | https://pub.njleg.gov/Bills/2024/A5000/4682_I1.HTM |
Loading...